UBT251 Injection Phase II Study (Overweight or Obesity)

Clinical trial NCT07177469 · COMPLETED

Trial details

NCT number: NCT07177469
Sponsor: The United Bio-Technology (Hengqin) Co., Ltd.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Obesity &Amp; Overweight

Start date: 2025-03-14
Primary completion: 2025-10-22
Enrollment: 205

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.